News Hamlet Pharma is proud to announce detailed timelines for the completion of the Phase I/II bladder cancer study
News The therapeutic effect of Alpha1H, Hamlet Pharma’s drug candidate, increases substantially with the treatment dose
News Prof. Catharina Svanborg appointed Chief Medical Officer of HAMLET Pharma, overseeing clinical trials
